Max Robotics — Global Service Robot Directory + US Certification

About

Je Jong Kim is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques for bladder cancer, with a particular focus on robot-assisted radical cystectomy (RARC). His major contributions lie in refining and validating the safety and efficacy of total intracorporeal urinary diversion (ICUD) following RARC, a technically demanding procedure that avoids external incisions for urinary reconstruction. In his landmark 2016 study, which has garnered 43 citations, Kim demonstrated that ICUD offers comparable perioperative outcomes and early oncologic results to traditional extracorporeal diversion, while potentially reducing complications. Earlier, his foundational 2009 work on the feasibility of extended pelvic lymphadenectomy during RARC—cited 7 times—helped establish that robotic platforms could achieve the thorough nodal dissection critical for accurate staging and improved survival. Through these studies, Kim has been instrumental in pushing the boundaries of robotic urologic oncology, showing that complex reconstructive steps can be performed entirely inside the body. His work continues to influence surgical protocols and training, making him a respected voice in the evolution of bladder cancer surgery.